Search

Your search keyword '"Cristina Alba"' showing total 12 results
Start Over Author "Cristina Alba" Journal gastroenterology
12 results on '"Cristina Alba"'

3. Can COVID-19 trigger de novo inflammatory bowel disease?

Author

Cristina Alba, Joaquín Fisac, and Carlos Taxonera

Subjects
2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Hepatology, business.industry, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Gastroenterology, diarrhea, Inflammatory Bowel Diseases, COVID-19, medicine.disease, Inflammatory bowel disease, Ulcerative colitis, inflammatory bowel diseases, Article, Diarrhea, Immunology, Medicine, Humans, Colitis, Ulcerative, Female, medicine.symptom, business, ulcerative colitis
Published
2020

4. What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?

Author

Cristina Alba, David Olivares, and Carlos Taxonera

Subjects
medicine.medical_specialty, 2019-20 coronavirus outbreak, Hepatology, Coronavirus disease 2019 (COVID-19), business.industry, Incidence (epidemiology), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Gastroenterology, MEDLINE, Inflammatory Bowel Diseases, Internal medicine, medicine, In patient, business
Published
2021

5. Mo1765 – Real-Life Experience with Long-Term Maintenance of Golimumab in Ulcerative Colitis Patients

Author

Cristina Alba, Noelia Cano-Sanz, Natalia García-Morales, Belén Beltrán, Carlos Taxonera Samso, Isabel Vera, Monica Sierra-Ausin, Federico Bertoletti, David Martí, Esther Garcia-Planella, R. Pajares, María Pilar Ballester, M Boscá-Watts, Noemí Manceñido Marcos, Saioa Rubio, Marta Calvo, Óscar Nantes Castillejo, Pilar Nos, Antonio Cañada, and Marisa Iborra

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Long term maintenance, medicine.disease, business, Ulcerative colitis, Golimumab, medicine.drug
Published
2019

6. Serial Tuberculin Skin Test Improves the Detection of Latent Tuberculosis Infection in Inflammatory Bowel Disease Patients

Author

Ruth de Francisco, Jesús Legido, Guillermo Bastida, Sabino Riestra Menendez, Óscar Nantes, Ángel Ponferrada, María Chaparro, Federico Argüelles-Arias, Cristina Alba, Pilar Martínez-Montiel, Carlos Taxonera Samso, P. López, Cristina Verdejo, Ignacio Marín-Jiménez, María del Mar Sanz Martín, Martín-Arranz, M. Rivero, Javier P. Gisbert, Luísa Castro, David Olivares, Cristina Suárez Ferrer, Daniel Carpio, and Fernando Bermejo

Subjects
Hepatology, Latent tuberculosis, business.industry, Immunology, Gastroenterology, Medicine, Tuberculin, Skin test, business, medicine.disease, Inflammatory bowel disease
Published
2017

8. Sa1955 Comparison of Four Assay Kits for Measuring Infliximab Trough Levels and Antibodies to Infliximab in Patients With Inflammatory Bowel Disease

Author

David Olivares, Enrique Rey, Carlos Taxonera, Cristina Alba, Lidia Fernández Paredes, Juan L. Mendoza, Silvia Sánchez-Ramón, and Irene Pérez Enciso

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Trough (economics), Inflammatory bowel disease, Infliximab, 03 medical and health sciences, Antibodies to infliximab, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, 030211 gastroenterology & hepatology, In patient, business, medicine.drug
Published
2016

9. Tu1107 Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis

Author

Xavier Calvet, Antonio Rodríguez, Javier P. Gisbert, Cristina Alba, María Chaparro, Cristobal De la Coba, Ignacio Fernández-Blanco, David Olivares, Carlos Taxonera, Fernando Bermejo, Manuel Barreiro-de Acosta, José Lázaro Pérez-Calle, David Busquets, Eva Iglesias Flores, Pilar López-Serrano, A. Díaz, R. Pajares, Fernando Muñoz, and Marta Calvo

Subjects
Hepatology, business.industry, Gastroenterology, Dose escalation, Adalimumab, Medicine, business, medicine.disease, Humanities, Ulcerative colitis, medicine.drug
Abstract

Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis Carlos Taxonera, Eva Iglesias Flores, Fernando Munoz, Marta Calvo, Manuel Barreiro-de Acosta, David Busquets, Xavier Calvet, Antonio Rodriguez, R. Pajares, Javier P. Gisbert, Pilar Lopez-Serrano, Jose Lazaro Perez-Calle, Angel Ponferrada Diaz, Cristobal De la Coba, Fernando Bermejo, Maria Chaparro, Cristina Alba, David Olivares, Ignacio Fernandez-Blanco

Published
2015

10. Serial Tuberculin Skin Tests to Detect Latent Tuberculosis in Inflammatory Bowel Disease Patients Receiving Infliximab Therapy

Author

Marta Barceló, Manuel Díaz-Rubio, Cristina Alba, Carlos Taxonera, Juan L. Mendoza, Natalia López-Palacios, and Dulce M. Cruz-Santamaría

Subjects
Infliximab therapy, medicine.medical_specialty, Hepatology, Latent tuberculosis, business.industry, Immunology, Gastroenterology, Medicine, Tuberculin, business, medicine.disease, Dermatology, Inflammatory bowel disease
Published
2011

11. Decreasing Rates of Hospital Admissions for Inflammatory Bowel Disease Between 2000 and 2009

Author

Manuel Díaz-Rubio, Dulce M. Cruz-Santamaría, Carlos Taxonera, María M. Cañas, Cristina Alba, Juan L. Mendoza, Norberto Mañas, Natalia López-Palacios, and Maria A. Tejero

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, business, medicine.disease, Inflammatory bowel disease
Published
2011

12. Is intensity of heartburn a relevant clinical feature?

Author

Cristina Alba, Enrique Rey, Angel Alvarez-Sanchez, and Manuel Díaz-Rubio

Subjects
Hepatology, Feature (computer vision), Computer science, business.industry, Gastroenterology, medicine, Heartburn, Pattern recognition, Artificial intelligence, medicine.symptom, business, Intensity (physics)
Published
2003

Catalog

Books, media, physical & digital resources
See catalog results